Veritable’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Veritable’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,200	Closed	-$19K	–	929
2022 Q2	$19K	Buy	+24,200	New	+$21.3K	﹤0.01%	893

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Veritable's SPPI Position: Q3 2022 in Review

Veritable sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 24,200 shares — an estimated $19K sold.

Veritable first reported a position in SPPI in Q2 2022 and held it in 1 quarter. The position peaked at $19K in Q2 2022. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

Veritable reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
Veritable sold 24,200 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $19K.
Veritable first reported a position in Spectrum Pharmaceuticals Inc in Q2 2022 and held it in 1 quarter.
Veritable's Spectrum Pharmaceuticals Inc position peaked at $19K in Q2 2022.
75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Veritable's 13F filing for Q3 2022, filed 14 Nov 2022.